Artificial intelligence is rapidly transforming biologics discovery, but the industry's focus is shifting from generatin...
Despite decades of advances in oncology, many solid tumours remain difficult to treat effectively without exposing patie...
Chime Biologics, a global biologics contract development and manufacturing organisation (CDMO), has announced the inaugu...
As advanced therapeutics move from scientific promise to commercial reality, the industry's focus is shifting be...
The RNA revolution is entering a new chapter. While mRNA transformed the industry's perception of nucleic acid therapeut...
Cancer drug discovery is entering a more disciplined era. Investors, partners, and clinicians are increasingly focused o...
Cancer immunotherapy is entering a new phase—one that extends beyond targeting individual tumour cells and towards...
After several years of volatility, biotechnology financing has returned—but under very different rules. Investors ...
As biotechnology enters an increasingly data-driven era, organisations are rethinking how discovery, clinical developmen...
As biologics and cell and gene therapies continue to advance, manufacturing infrastructure is emerging as a critical det...
As cell and gene therapies move from clinical promise to commercial reality, the industry is increasingly recognising th...
Cell and gene therapies have transformed the treatment landscape for complex diseases, yet scaling these innovations bey...
As biotechnology enters a new phase of disciplined investment and precision-driven innovation, leaders who can bridge sc...
As biologics become increasingly sophisticated and development timelines continue to shrink, the role of Contrac...
At BIO International Convention 2026 in San Diego, BioSpectrum Asia spoke with Dr. Christoffer Norn, Co-founder and CEO ...
Murj®, a US-based cardiac device management software company, has announced its official expansion into the Australi...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Japan-based Shimadzu Corporation has released the PPSQ-51A/53A SPD-40 model protein sequencers. These instruments c...
MediThinQ, a South Korea-based innovator in surgical visualisation technologies, has entered into an exclusive multi-yea...
Qiagen has announced that its QIAstat-Dx Meningitis/Encephalitis (ME) Panel has been included in the Australian Register...
As life sciences laboratories embrace automation, digitalisation, and increasingly complex research workflows, technolog...
Japan-based startup Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, a colla...
South Korea-based LG AI Research has signed a master agreement with D&D Pharmatech for a joint next-generation oral ...
Japan-based Fujifilm Corporation and Horiba have announced the co-development of a high-sensitivity inline Raman measure...
StemSight, a Finnish biotechnology startup developing off-the-shelf regenerative cell therapies for curing blindness, ha...
